{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:54:29Z","timestamp":1762296869130},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.brainres.2004.10.038","type":"journal-article","created":{"date-parts":[[2004,12,19]],"date-time":"2004-12-19T11:20:11Z","timestamp":1103455211000},"page":"202-210","source":"Crossref","is-referenced-by-count":46,"title":["Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats"],"prefix":"10.1016","volume":"1031","author":[{"given":"Marilise Escobar","family":"Burger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roselei","family":"Fachineto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrei","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Callegari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Batista Teixeira","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2004.10.038_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00213-002-1081-7","article-title":"Effects of melatonin on orofacial movements in rats","volume":"161","author":"Abilio","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2004.10.038_bib2","first-page":"7109","article-title":"Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione\/reduced glutathione ratio (GSSG\/GSH) enhancement in rats","volume":"2","author":"Abilio","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","article-title":"Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?","volume":"61","author":"Andreassen","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2004.10.038_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/niox.1999.0229","article-title":"Nitric oxide, superoxide, and hydrogen peroxide production in brain mitochondria after haloperidol treatment","volume":"3","author":"Arnaiz","year":"1999","journal-title":"Nitric Oxide: Biol. Chem."},{"key":"10.1016\/j.brainres.2004.10.038_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(73)90028-9","article-title":"Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol","volume":"22","author":"Baggiolini","year":"1973","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1176\/ajp.137.10.1163","article-title":"Tardive diskinesia: summary of a task force report of the American Psychiatric Association","volume":"137","author":"Baldessarini","year":"1980","journal-title":"Am. J. Psych."},{"key":"10.1016\/j.brainres.2004.10.038_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0006-8993(85)90532-3","article-title":"The effects of haloperidol on synaptic patterns in the rat striatum","volume":"329","author":"Benes","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.10.038_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0197-4580(97)00152-8","article-title":"Effects of age on a new model of tardive dyskinesia","volume":"18","author":"Bergamo","year":"1997","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.brainres.2004.10.038_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(84)90438-2","article-title":"Homovanillic acid in caudate and pre-frontal cortex following neuroleptics","volume":"99","author":"Bowers","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0278-5846(02)00344-5","article-title":"Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum","volume":"27","author":"Burger","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0278-5846(01)00255-X","article-title":"The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats","volume":"26","author":"Calvente","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib12","series-title":"Pyschopharmacology: The Fourth Generation of Progress","first-page":"1497","article-title":"Tardive dyskinesia-pathophysiology","author":"Casey","year":"1995"},{"key":"10.1016\/j.brainres.2004.10.038_bib13","first-page":"5","article-title":"Tardive dyskinesia: pathophysiology and animal models","volume":"61","author":"Casey","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1046\/j.1471-4159.1999.721394.x","article-title":"Oxidative stress, mitochondrial function, and acute glutamate excitotoxicity in cultured cerebellar granule cells","volume":"72","author":"Castilho","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2004.10.038_bib15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0006-3223(98)00029-8","article-title":"Striatal enlargement in rats chronically treated with neuroleptic","volume":"44","author":"Chakos","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib16","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0006-3223(01)01271-9","article-title":"Management of treatment resistance in schizophrenia","volume":"50","author":"Conley","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.brainres.2004.10.038_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.brainres.2004.10.038_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.1995.1163","article-title":"Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases","volume":"134","author":"Dawson","year":"1995","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00002826-199112000-00009","article-title":"Excitotoxic mechanisms may be involved in the pathophysiology of tardive dyskinesia","volume":"14","author":"de Keyser","year":"1991","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/exnr.1995.1020","article-title":"Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia","volume":"133","author":"Delfs","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2004.10.038_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-2999(99)00589-0","article-title":"Chronic haloperidol treatment impairs glutamate transport in the rat striatum","volume":"382","author":"De Souza","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0278-5846(01)00295-0","article-title":"Behavioral effects of MK-801 on reserpine-treated mice","volume":"26","author":"Dutra","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib24","first-page":"575","article-title":"Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders","volume":"47","author":"Ebadi","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2004.10.038_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/schbul\/23.4.583","article-title":"Treatment of tardive dyskinesia","volume":"23","author":"Egan","year":"1997","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainres.2004.10.038_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1176\/ajp.147.4.505","article-title":"Vitamin E in the treatment of tardive dyskinesia","volume":"147","author":"Elkashef","year":"1990","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.brainres.2004.10.038_bib27","first-page":"125","article-title":"Neurotoxic effect of 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl(-pyridinium) (HP+), a major metabolite of haloperidol in the dopaminergic system in vitro and in vivo","volume":"12","author":"Fang","year":"1996","journal-title":"Biog. Amines"},{"key":"10.1016\/j.brainres.2004.10.038_bib28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0166-2236(84)80254-4","article-title":"Neurobiological substrates of tardive dyskinesia: the GABA hypothesis","volume":"7","author":"Fibiger","year":"1984","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2004.10.038_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00002826-199302000-00012","article-title":"An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia","volume":"1","author":"Gunne","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/309347a0","article-title":"Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis","volume":"309","author":"Gunne","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2004.10.038_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130050599","article-title":"Mixture in the distribution of haloperidol induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia","volume":"137","author":"Hashimoto","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2004.10.038_bib32","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s007020050234","article-title":"Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia","volume":"106","author":"Ikeda","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2004.10.038_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00023210-199605010-00002","article-title":"Drug-resistant schizophrenia-treatment options","volume":"5","author":"Jalenques","year":"1996","journal-title":"CNS Drugs"},{"key":"10.1016\/j.brainres.2004.10.038_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0306-4522(90)90424-3","article-title":"Neuropeptide changes in a primate model (Cebus apella) for tardive dyskinesia","volume":"37","author":"Johansson","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2004.10.038_bib35","series-title":"Psychopharmacology: The Fourth Generation of Progress","first-page":"1485","article-title":"Tardive dyskinesia epidemiological and clinical presentation","author":"Kane","year":"1995"},{"key":"10.1016\/j.brainres.2004.10.038_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archpsyc.1982.04290040069010","article-title":"Tardive dyskinesia: prevalence and risk factors, 1959 to 1979","volume":"39","author":"Kane","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-2999(92)90070-K","article-title":"Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats","volume":"212","author":"Kaneda","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1358\/dot.2001.37.2.834327","article-title":"Tardive dyskinesia: an update","volume":"37","author":"Kulkarni","year":"2001","journal-title":"Drugs Today"},{"key":"10.1016\/j.brainres.2004.10.038_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0891-5849(95)00014-O","article-title":"Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices","volume":"19","author":"Langeveld","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainres.2004.10.038_bib40","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0028-3908(03)00314-9","article-title":"Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats","volume":"45","author":"Lau","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2004.10.038_bib41","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.1991.01810360061009","article-title":"Oxygen free radicals and neuropsychiatric illness","volume":"48","author":"Lohr","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib42","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1460-9568.2002.01944.x","article-title":"Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to 'early onset' vacuous chewing","volume":"15","author":"Marchese","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2004.10.038_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/S000712500029692X","article-title":"Dimensions of outcome with clozapine","volume":"160","author":"Meltzer","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0006-8993(89)90867-6","article-title":"Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment","volume":"489","author":"Meshul","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.10.038_bib45","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1046\/j.1471-4159.1996.67051965.x","article-title":"Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses","volume":"67","author":"Meshul","year":"1996","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.brainres.2004.10.038_bib46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF02247334","article-title":"Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol","volume":"125","author":"Meshul","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2004.10.038_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-4522(01)00455-9","article-title":"Acute administration of haloperidol induces apoptosis of neurones in the striatum and substantia nigra in the rat","volume":"109","author":"Mitchell","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2004.10.038_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00008877-200105000-00006","article-title":"Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide","volume":"12","author":"Naidu","year":"2001","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(01)01385-1","article-title":"Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats","volume":"430","author":"Naidu","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bjp.0704717","article-title":"Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms","volume":"13","author":"Naidu","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/109662003322233503","article-title":"Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action","author":"Naidu","year":"2003","journal-title":"J. Med. Food"},{"key":"10.1016\/j.brainres.2004.10.038_bib52","first-page":"850","article-title":"Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats","volume":"257","author":"Neisewander","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2004.10.038_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-8993(91)90710-D","article-title":"Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment","volume":"558","author":"Neisewander","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.10.038_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02244874","article-title":"Dose-dependent differences in the development of reserpine-induced oral-dyskinesia in rats: support for a model of tardive dyskinesia","volume":"116","author":"Neisewander","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2004.10.038_bib55","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1046\/j.1471-4159.2002.01075.x","article-title":"Neuronal-induced and glutamate-dependent activation of glial glutamate transporter function","volume":"82","author":"Poitry-Yamate","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2004.10.038_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0893-133X(01)00364-5","article-title":"Mechanisms underlying the protective potential of alpha-tocopherol (vitamin E) against haloperidol-associated neurotoxicity","volume":"26","author":"Post","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2004.10.038_bib57","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0278-5846(99)00074-3","article-title":"Effects of buspirone on an animal model of tardive dyskinesia","volume":"23","author":"Queir\u00f3z","year":"1999","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-2999(98)00546-9","article-title":"Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats","volume":"356","author":"Queir\u00f3z","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(01)02455-6","article-title":"Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors","volume":"904","author":"Raghavendra","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.10.038_bib60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1054-3589(08)60948-5","article-title":"Heterogeneity and functional subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system","volume":"37","author":"Robinson","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1079\/BJN19900114","article-title":"Undernutrition during the preweaning period changes calcium ATPase and ADPase activities of synaptosomal fractions of weanling rats","volume":"63","author":"Rocha","year":"1990","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.brainres.2004.10.038_bib62","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0278-5846(02)00221-X","article-title":"The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats","volume":"26","author":"Rosengarten","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib63","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/j.1440-1614.2000.00737.x","article-title":"The current status of tardive dyskinesia","volume":"34","author":"Sachdev","year":"2000","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s002130000570","article-title":"Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats","volume":"153","author":"Sakai","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2004.10.038_bib65","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-8993(77)90538-8","article-title":"Striatal lesions with kainic acid: neurochemical characteristics","volume":"127","author":"Schwarcz","year":"1977","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.10.038_bib66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0304-3940(91)90477-B","article-title":"Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride","volume":"129","author":"See","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2004.10.038_bib67","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/00001756-199509000-00021","article-title":"Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex","volume":"11","author":"See","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/j.brainres.2004.10.038_bib68","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0006-8993(95)01114-5","article-title":"Chronic haloperidol-induced changes in regional dopamine release and metabolism and neurotensin content in rats","volume":"704","author":"See","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2004.10.038_bib69","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archpsyc.58.11.1049","article-title":"Melatonin treatment for tardive dyskinesia\u2014a double-blind, placebo-controlled, crossover study","volume":"58","author":"Shamir","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib70","first-page":"1137","article-title":"Oxidative stress and thiol modification induced by chronic administration of haloperidol","volume":"265","author":"Shivakumar","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2004.10.038_bib71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0166-4328(01)00409-0","article-title":"Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice","volume":"132","author":"Silva","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2004.10.038_bib72","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(03)02124-1","article-title":"Possible antioxidant and neuroprotective mechanisms of FK506 in attenuating haloperidol-induced orofacial dyskinesia","volume":"477","author":"Singh","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(99)00021-3","article-title":"The treatment of tardive dyskinesia\u2014a systematic review and meta-analysis","volume":"39","author":"Soares","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainres.2004.10.038_bib74","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(97)01271-5","article-title":"Acute reserpine administration elicits long-term spontaneous oral dyskinesia","volume":"337","author":"Sussman","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2004.10.038_bib75","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1460-9568.1997.tb01478.x","article-title":"Neuronal and glial glutamate transporters possess a SH-based redox regulatory mechanism","volume":"9","author":"Trotti","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2004.10.038_bib76","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.pharmtox.42.082701.160735","article-title":"Glutamatergic mechanisms in schizophrenia","volume":"42","author":"Tsai","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.brainres.2004.10.038_bib77","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/ajp.155.9.1207","article-title":"Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia","volume":"155","author":"Tsai","year":"1998","journal-title":"Am. J. Psych."},{"key":"10.1016\/j.brainres.2004.10.038_bib78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","article-title":"The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?","volume":"26","author":"Turrone","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainres.2004.10.038_bib79","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1300233","article-title":"Differential effects of within-day continuous vs transient dopamine D-2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats","volume":"28","author":"Turrone","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2004.10.038_bib80","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/BF00441188","article-title":"Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy","volume":"1","author":"Uhrbrand","year":"1960","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.brainres.2004.10.038_bib81","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0278-5846(97)00108-5","article-title":"Effects of monosialoganglioside on a new model of tardive dyskinesia","volume":"21","author":"Vital","year":"1997","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2004.10.038_bib82","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","article-title":"Spontaneous orofacial movements induced by very long-term neuroleptic drug administration: phenonomenology, pathophysiology and putative relationship to tardive dyskinesia","volume":"101","author":"Waddington","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2004.10.038_bib83","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1471-4159.1992.tb10048.x","article-title":"Dopaminergic modulation of glutamate release in striatum as measured by microdialysis","volume":"58","author":"Yamamoto","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2004.10.038_bib84","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/(SICI)1098-2396(19991201)34:3<192::AID-SYN4>3.0.CO;2-L","article-title":"Neurochemical changes in the entopeduncular nucleos and increased oral behavior in rats treated subchronically with clozapine or haloperidol","volume":"34","author":"Yu","year":"1999","journal-title":"Synapse"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899304017688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899304017688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T22:58:53Z","timestamp":1548889133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899304017688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0006899304017688"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2004.10.038","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}